Skip to main content

CVE:MDX - MedX Health Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: C$0.00
  • Forecasted Upside: -100.00 %
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
C$0.15
▼ -0.01 (-6.25%)
1 month | 3 months | 12 months
Get New MedX Health Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for MDX and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for MDX

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
C$0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for MedX Health in the last 3 months. The average price target is C$0.00, with a high forecast of C$0.00 and a low forecast of C$10,000,000.00. The average price target represents a -100.00% upside from the last price of C$0.15.

N/A

The current consensus among 0 contributing investment analysts is to n/a stock in MedX Health. This rating has held steady since March 2021, when it changed from a Buy consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/22/2019
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/20/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/20/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/18/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/16/2020
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/14/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/15/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/15/2021

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
3/25/2020Beacon SecuritiesReiterated RatingBuy
i
Rating by D. Cooper at Beacon Securities
(Data available from 5/16/2016 forward)
MedX Health logo
MedX Health Corp., a medical device and software company, develops, manufactures, and markets skin related screening tools and phototherapy devices for pain relief and tissue repair in Canada, the United States, Europe, Australia, Asia, and Latin America. The company offers SIAscopy, a medical device technology that is used to scan skin for suspicious moles and lesions; and phototherapeutic medical devices, which use light energy in lower-level laser and LED to provide treatment for pain and tissue damage in the rehabilitation market. Its product portfolio includes SIMSYS, a skin analysis system; MoleMate, a non-invasive screening device that is designed for general practitioners and skin specialists; and SIAMETRICS, a skin visualization and measurement technology that allows cosmetic formulators and active ingredient manufacturers to measure and quantify the concentrations of melanin, haemoglobin, and collagen in living human skin. The company also provides rehab laser console systems, dental laser console systems, OraLase portable laser probes, MedX home treatment systems, and rehab portable lasers. In addition, it operates DermSecure telemedicine platform that enables the Web-based operation of SIAscopy scanning technology and allows the company to deploy its technology in networks of third-party locations from which patients' mole and lesion scans can be connected to specialist physicians for remote assessment. The company was founded in 1999 and is headquartered in Mississauga, Canada.
Read More

Today's Range

Now: C$0.15
C$0.15
C$0.16

50 Day Range

MA: C$0.18
C$0.15
C$0.20

52 Week Range

Now: C$0.15
C$0.10
C$0.26

Volume

92,700 shs

Average Volume

342,617 shs

Market Capitalization

C$26.39 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of MedX Health?

The following Wall Street research analysts have issued reports on MedX Health in the last year:
View the latest analyst ratings for MDX.

What is the current price target for MedX Health?

0 Wall Street analysts have set twelve-month price targets for MedX Health in the last year. has the lowest price target set, forecasting a price of C$10,000,000.00 for MedX Health in the next year.
View the latest price targets for MDX.

What is the current consensus analyst rating for MedX Health?

MedX Health currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for MDX.

What other companies compete with MedX Health?

How do I contact MedX Health's investor relations team?

MedX Health's physical mailing address is 1495 Bonhill Rd Unit 1, MISSISSAUGA, ON L5T 1M2, Canada. The company's listed phone number is +1-905-6704428. The official website for MedX Health is www.medxhealth.com.